HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Minimal change disease in a patient receiving IFN-alpha therapy for chronic hepatitis C virus infection.

Abstract
Chronic hepatitis C virus (HCV) infection is associated with several extrahepatic syndromes. The principal types of renal disorders associated with chronic HCV infection are cryoglobulinemia or noncryoglobulinemic membranoproliferative glomerulonephritis (MPGN). Interferon-alpha (IFN-alpha) may precipitate or exacerbate the occurrence of MPGN. Our patient was a 32-year-old man who tested positive for HCV in July 1997. The patient was treated with IFN-alpha in another medical center for 6 months because his liver biopsy showed chronic active hepatitis. In December 1998, he applied to our clinic for a follow-up examination. The level of aspartate aminotransferase (AST) was 44 U/L, and that of alanine aminotransferase (ALT) was 69 U/L. HCV RNA was positive in serum, and chronic HCV infection was detected by liver biopsy. IFN-alpha therapy (5 million U/day) was administered for 6 months longer. In May 1999, the patient came to our polyclinic with edema of the feet and legs. We detected proteinuria, serum cholesterol of 269 mg/dl, AST of 50 U/L, ALT of 41 U/L, serum total protein of 3.4 g/dl, serum albumin of 1.2 g/dl, positive cryoglobulin, and urine protein of 9.84 g/day. Cryoglobulinemic MPGN was suspected and kidney biopsy was performed, resulting in a diagnosis of minimal change disease (MCD).
AuthorsUfuk Dizer, Can Murat Beker, Izzet Yavuz, Mesut Ortatatli, Volka Ozguven, Alaaddin Pahsa
JournalJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research (J Interferon Cytokine Res) Vol. 23 Issue 1 Pg. 51-4 (Jan 2003) ISSN: 1079-9907 [Print] United States
PMID12639299 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antiviral Agents
  • Interferon Type I
  • Recombinant Proteins
Topics
  • Adult
  • Antiviral Agents (adverse effects)
  • Cryoglobulinemia (etiology)
  • Glomerulonephritis, Membranoproliferative (etiology)
  • Hepatitis C, Chronic (complications, drug therapy)
  • Humans
  • Interferon Type I (adverse effects)
  • Male
  • Nephrosis, Lipoid (diagnosis, etiology)
  • Recombinant Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: